| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.76▲ | 1.76▲ | 1.76▲ | 1.76▲ | 1.78▼ |
| MA10 | 1.73▲ | 1.73▲ | 1.74▲ | 1.78▼ | 1.78▼ |
| MA20 | 1.75▲ | 1.76▲ | 1.77▲ | 1.80▼ | 1.63▲ |
| MA50 | 1.80▼ | 1.79▼ | 1.79▼ | 1.80▼ | 1.78▼ |
| MA100 | 1.81▼ | 1.84▼ | 1.78▼ | 1.63▲ | 1.89▼ |
| MA200 | 1.79▼ | 1.66▲ | 1.66▲ | 1.74▲ | 2.29▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.008▲ | 0.007▲ | 0.002▲ | -0.010▼ | 0.025▲ |
| RSI | 53.171▲ | 52.460▲ | 50.420▲ | 48.601▼ | 52.248▲ |
| STOCH | 79.167 | 73.810 | 57.598 | 21.575 | 30.002 |
| WILL %R | 0.000▲ | -5.882▲ | -33.333 | -74.532 | -64.997 |
| CCI | 114.899▲ | 93.976 | 43.924 | -46.200 | 0.691 |
|
Wednesday, July 22, 2026 10:00 PM
Innate Pharma S.A. is a global, clinical-stage biotechnology company developing immunotherapies for cancer patients. Leveraging its expertise on antibody-engineering and innovative target ...
|
|
Monday, July 20, 2026 10:00 PM
Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company"), today announced the completion of enrollment in the dose escalation of the Phase 1 study of IPH4502 (NCT06781983), its ...
|
|
Thursday, July 16, 2026 12:59 PM
Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 22/07/26 | 1.775 | 1.775 | 1.775 | 1.775 | 1,919 |
| 21/07/26 | 1.76 | 1.77 | 1.74 | 1.765 | 2,533 |
| 20/07/26 | 1.7152 | 1.73 | 1.7152 | 1.73 | 2,727 |
| 17/07/26 | 1.72 | 1.75 | 1.72 | 1.75 | 10,425 |
| 16/07/26 | 1.76 | 1.7944 | 1.76 | 1.775 | 5,087 |
| 15/07/26 | 1.7998 | 1.81 | 1.79 | 1.80 | 3,045 |
| 14/07/26 | 1.82 | 1.89 | 1.79 | 1.79 | 4,901 |
| 13/07/26 | 1.78 | 1.84 | 1.74 | 1.79 | 11,979 |
| 10/07/26 | 1.79 | 1.81 | 1.76 | 1.7925 | 11,787 |
| 09/07/26 | 1.83 | 1.83 | 1.7617 | 1.79 | 2,236 |
|
|
||||
|
|
||||
|
|